戻る戻るImmix Biopharma, Inc.のNet income before discontinued operations (非継続事業を含む純利益)
年間データ
−28.00 M
−21.00 M
−14.00 M
−7.00 M
0.00
直近12ヶ月
−21.89 M
−6.46 M
−41.91%
2023
−15.43 M
−7.20 M
−87.44%
2022
−8.23 M
+16.15 M
+66.25%
2021
−24.38 M
−23.24 M
−2.02 K%
2020
−1.15 M
−175.05 K
−17.99%
四半期データ
Q1 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
−8.00 M
−6.00 M
−4.00 M
−2.00 M
0.00
Q3 '24
−7.15 M
−2.76 M
−62.75%
Q2 '24
−4.39 M
+866.05 K
+16.47%
Q1 '24
−5.26 M
−169.49 K
−3.33%
Q4 '23
−5.09 M
−808.84 K
−18.90%
Q3 '23
−4.28 M
−704.45 K
−19.70%
Q2 '23
−3.58 M
−1.10 M
−44.22%
Q1 '23
−2.48 M
+1.32 M
+34.74%
Q4 '22
−3.80 M
−2.26 M
−147.54%